SHIFTBIO developed diverse
oustanding platform technologies
based on exosome.

Development of Exosome Platform Technology to solve unmet medical needs

SBI-2OO. InProDel
Efficient loading transcription factors

into exosomes for
 intracellular delivery

Even though transcription Factors  show systemic efficacy, they cannot be made into drugs low stability in vivo.

SHIFTBIO can load transcription factors into exosomes in free-form and avoid the endosomal/lysosomal pathway through fusogenic peptides,  thereby maximizing the efficiency of intracellular transcription factor delivery.

InProDel is a platform technology to automatically load free-form transcription factor inside the exosome and efficiently deliver into target cells.

SHIFTBIO developed diverse outstanding
platform technologies based on exosome.

Development of Exosome Platform Technology to solve unmet medical needs

InProDel is a platform technology to automatically load free-form transcription factor
inside the exosome and efficiently deliver into target cells.